---
schema_version: "secwatch.filing_event.v1"
accession: "0001171843-26-004863"
form_type: "8-K"
ticker: "PROF"
cik: "0001628808"
company_name: "Profound Medical Corp."
filed_at: "2026-07-24T15:58:37+00:00"
generated_at: "2026-07-24T16:03:04.118476+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# CAPTAIN trial: TULSA preserves penile length vs 0.65 cm loss with robotic RP at 1 month

## Summary
- No median change in penile length at 1 month for TULSA vs 0.65 cm reduction for robotic RP.
- Between-arm difference in penile length change was 0.42 cm (p<0.001), statistically significant.
- TULSA previously showed statistically significant superiority over robotic RP in erectile function and urinary continence at 6 months.
- Data presented at Society of Robotic Surgery Annual Meeting by Dr. Xiaosong Meng of UT Southwestern.

## SEC filing metadata
- accession: 0001171843-26-004863
- form_type: 8-K
- ticker: PROF
- cik: 0001628808
- company_name: Profound Medical Corp.
- filed_at: 2026-07-24T15:58:37+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1628808/000117184326004863/0001171843-26-004863-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1628808/000117184326004863/f8k_072426.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001171843-26-004863
- JSON: https://secwatch.observer/filing/0001171843-26-004863.json
- Plain text: https://secwatch.observer/filing/0001171843-26-004863.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.